What are the side effects of clozapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clozapine Side Effects: Comprehensive Overview

Clozapine is associated with numerous serious and potentially life-threatening side effects, including severe neutropenia, cardiovascular complications, seizures, and metabolic disturbances, requiring strict monitoring protocols and careful management. 1

Major Adverse Effects

Hematologic Effects

  • Severe neutropenia/agranulocytosis: Occurs in approximately 1% of patients 2
    • Requires mandatory blood monitoring:
      • Weekly blood cell counts for first 6 months
      • Biweekly thereafter
      • Continue monitoring for 4 weeks after discontinuation 3
    • Management protocol:
      • If WBC <2,000/mm³ or ANC <1,000/mm³: Stop medication immediately, monitor daily
      • If WBC 2,000-3,000/mm³ or ANC 1,000-1,500/mm³: Stop medication, monitor daily until WBC >3,000 and ANC >1,500
      • If WBC 3,000-3,500/mm³: Repeat count with differential, monitor biweekly until WBC >3,500/mm³ 3

Cardiovascular Effects

  • Myocarditis and cardiomyopathy: Potentially fatal, highest risk in first month 1, 4
  • QT interval prolongation: Increases risk of arrhythmias 2, 1
  • Orthostatic hypotension and syncope: Common, especially during initiation 1
  • Tachycardia: Reported in 25% of patients 1
  • Hypertension: Less common but significant 1

Neurological Effects

  • Seizures: Dose-dependent, occurring in approximately 3% of patients 1
  • Sedation/drowsiness: Very common (39% of patients) 1
  • Dizziness/vertigo: Common (19% of patients) 1
  • Minimal extrapyramidal symptoms: Unlike typical antipsychotics 5

Gastrointestinal Effects

  • Hypersalivation: Extremely common (31% of patients) 1
  • Constipation: Common (14% of patients), can lead to serious complications 1
  • Gastrointestinal hypomotility: Can cause severe complications 1
  • Nausea and vomiting: Common 1

Metabolic Effects

  • Weight gain: Significant concern, requires monitoring 3, 1
  • Hyperglycemia and diabetes: Requires regular monitoring 3, 1
  • Dyslipidemia: Requires regular monitoring 3, 1

Other Significant Effects

  • Fever: Reported in 5% of patients 1
  • Anticholinergic effects: Dry mouth, visual disturbances, urinary abnormalities 1
  • Cognitive impairment: Interference with cognitive and motor performance 1
  • Rebound psychosis: Risk with abrupt discontinuation 1, 6

Monitoring Requirements

Baseline Assessments

  • Complete blood count with WBC ≥3,500/mm³
  • BMI and waist circumference
  • Blood pressure
  • Fasting glucose and lipid panel
  • ECG
  • Abnormal Involuntary Movement Scale (AIMS) assessment 2

Ongoing Monitoring

  • Hematologic: As outlined above
  • Metabolic parameters:
    • BMI: Monthly for first 3 months, then quarterly
    • Blood pressure, fasting glucose, lipids: After 3 months, then yearly 2
  • Cardiovascular: Regular assessment, especially during first month 4

Management of Common Side Effects

  • Sedation: Dose adjustment, administration at bedtime
  • Hypersalivation: Anticholinergic medications may help
  • Constipation: Dietary modifications, increased fluid intake, stool softeners
  • Weight gain: Lifestyle modifications, consider metformin or GLP-1 receptor agonists 3
  • Seizures: Dose reduction, consider anticonvulsant if necessary 1

Contraindications

  • History of clozapine-induced agranulocytosis or granulocytopenia
  • Myeloproliferative disorders
  • Concurrent medications that lower blood cell counts 2

Clozapine's side effect profile is extensive and requires vigilant monitoring, but its superior efficacy in treatment-resistant schizophrenia often justifies its use when managed appropriately 5, 7.

References

Guideline

Clozapine Management and Adverse Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Potentially fatal outcomes associated with clozapine.

Schizophrenia research, 2018

Research

Review and management of clozapine side effects.

The Journal of clinical psychiatry, 2000

Research

Clozapine: efficacy and safety.

Schizophrenia bulletin, 1995

Research

Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.

Clinical schizophrenia & related psychoses, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.